{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:50:33Z","timestamp":1792788633536,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clnesp.2026.103415","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:59:47Z","timestamp":1782284387000},"page":"103415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Intermittent fasting strategies for metabolic dysfunction-associated steatotic liver disease: A systematic review and frequentist network meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"75","author":[{"given":"Husam","family":"Abu Suilik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Farid Gadelmawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Rifai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moayad","family":"Alhawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdellrahman","family":"Ashour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Abdalshafy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Abdullah Bataineh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem","family":"Rezq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Bani Hani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0759-1010","authenticated-orcid":false,"given":"Ismail","family":"Elkhattib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abuelazm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2026.103415_bib1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.clnesp.2026.103415_bib2","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.clnesp.2026.103415_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/cancers16020259","article-title":"MASLD and the development of HCC: pathogenesis and therapeutic challenges","volume":"16","author":"Phoolchund","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.clnesp.2026.103415_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndrome"},{"key":"10.1016\/j.clnesp.2026.103415_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1433857","article-title":"Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases","volume":"12","author":"Sandireddy","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.clnesp.2026.103415_bib6","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2337\/dci24-0094","article-title":"Metabolic Dysfunction\u2013Associated Steatotic Liver Disease (MASLD) in people with diabetes: the need for screening and early intervention. A consensus report of the American diabetes Association","volume":"48","author":"Cusi","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnesp.2026.103415_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cld.2023.01.007","article-title":"Economic burden and patient-reported outcomes of non-alcoholic fatty liver disease","volume":"27","author":"Stepanova","year":"2023","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clnesp.2026.103415_bib8","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.84803","article-title":"Managing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the digital era: overcoming barriers to lifestyle change","author":"Kravchuk","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.clnesp.2026.103415_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2025.101903","article-title":"Updated recommendations for the management of Metabolic Dysfunction\u2013Associated Steatotic Liver Disease (MASLD) by the Latin American working group","volume":"30","author":"Diaz","year":"2025","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clnesp.2026.103415_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2478\/jtim-2019-0023","article-title":"Effect of weight reduction on histological activity and fibrosis of lean non-alcoholic steatohepatitis patient","volume":"7","author":"Alam","year":"2019","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.clnesp.2026.103415_bib11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s13679-019-00345-1","article-title":"Non-alcoholic fatty liver disease and obesity treatment","volume":"8","author":"Brunner","year":"2019","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.clnesp.2026.103415_bib12","series-title":"Effect of intermittent calorie restriction on Metabolic dysfunction-associated steatotic liver disease patients with abnormal glucose metabolism, clinicaltrials.gov","author":"Bian","year":"2024"},{"key":"10.1016\/j.clnesp.2026.103415_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0884533611405992","article-title":"Dietary adherence to long-term controlled feeding in a calorie-restriction study in overweight men and women","volume":"26","author":"Moreira","year":"2011","journal-title":"Nut in Clin Prac"},{"key":"10.1016\/j.clnesp.2026.103415_bib14","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.3390\/nu15163661","article-title":"Intermittent fasting and its effects on weight, glycemia, lipids, and blood pressure: a narrative review","volume":"15","author":"Naous","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2026.103415_bib15","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s11357-021-00335-z","article-title":"Intermittent fasting: from calories to time restriction","volume":"43","author":"Duregon","year":"2021","journal-title":"GeroScience"},{"key":"10.1016\/j.clnesp.2026.103415_bib16","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cmet.2016.06.001","article-title":"Fasting, circadian rhythms, and time-restricted feeding in healthy lifespan","volume":"23","author":"Longo","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.clnesp.2026.103415_bib17","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s12325-018-0746-5","article-title":"Intermittent fasting (alternate day fasting) in healthy, non-obese adults: protocol for a cohort trial with an embedded randomized controlled pilot trial","volume":"35","author":"Tripolt","year":"2018","journal-title":"Adv Ther"},{"key":"10.1016\/j.clnesp.2026.103415_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.16786","article-title":"A 5:2 intermittent fasting meal replacement diet and glycemic control for adults with diabetes: the EARLY randomized clinical trial","volume":"7","author":"Guo","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clnesp.2026.103415_bib19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s13679-018-0308-9","article-title":"Intermittent fasting: is the wait worth the weight?","volume":"7","author":"Stockman","year":"2018","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.clnesp.2026.103415_bib20","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/nutrit\/nuad015","article-title":"Metabolic impact of intermittent energy restriction and periodic fasting in patients with type 2 diabetes: a systematic review","volume":"81","author":"Van Den Burg","year":"2023","journal-title":"Nutr Rev"},{"key":"10.1016\/j.clnesp.2026.103415_bib21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3390\/biology14060669","article-title":"A biochemical view on intermittent fasting's effects on human physiology\u2014not always a beneficial strategy","volume":"14","author":"Zambuzzi","year":"2025","journal-title":"Biology"},{"key":"10.1016\/j.clnesp.2026.103415_bib22","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.clinthera.2025.01.007","article-title":"The effect of intermittent fasting diet in comparison with low-calorie diet on inflammation, lipid profile, glycemic index, liver fibrosis in patients with metabolic-associated fatty liver disease (MAFLD): a randomized controlled trial","volume":"47","author":"Karimi","year":"2025","journal-title":"Clin Ther"},{"key":"10.1016\/j.clnesp.2026.103415_bib23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/MEG.0000000000002715","article-title":"Intermittent fasting regimens for metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis of randomized controlled trials","volume":"36","author":"Abuelazm","year":"2024","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2026.103415_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.948655","article-title":"Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: a randomized controlled trial","volume":"9","author":"Kord Varkaneh","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnesp.2026.103415_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.orcp.2015.08.020","article-title":"Determinants of weight loss success with alternate day fasting","volume":"10","author":"Varady","year":"2016","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/j.clnesp.2026.103415_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnesp.2026.103415_bib27","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clnesp.2026.103415_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.clnesp.2026.103415_bib29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of non-alcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnesp.2026.103415_bib30","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s10620-014-3380-3","article-title":"Total body weight loss of \u2265 10 % is associated with improved hepatic fibrosis in patients with non-alcoholic steatohepatitis","volume":"60","author":"Glass","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnesp.2026.103415_bib31","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.3390\/nu15234870","article-title":"Time-restricted fasting improves liver steatosis in non-alcoholic fatty liver disease\u2014A single blinded crossover trial","volume":"15","author":"Feehan","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2026.103415_bib32","article-title":"The effects of time-restricted eating for patients with non-alcoholic fatty liver disease: a systematic review","volume":"10","author":"Lin","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnesp.2026.103415_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000212","article-title":"Intermittent fasting improves hepatic end points in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"7","author":"Lange","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.clnesp.2026.103415_bib34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.3513","article-title":"Effects of time-restricted eating on non-alcoholic fatty liver disease: the TREATY-FLD randomized clinical trial","volume":"6","author":"Wei","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clnesp.2026.103415_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cmet.2022.12.001","article-title":"Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: a randomized controlled trial","volume":"35","author":"Ezpeleta","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.clnesp.2026.103415_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1174293","article-title":"Alternate-day modified fasting diet improves weight loss, subjective sleep quality and daytime dysfunction in women with obesity or overweight: a randomized, controlled trial","volume":"10","author":"Hooshiar","year":"2023","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnesp.2026.103415_bib39","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s12013-024-01314-9","article-title":"Intermittent fasting regulates metabolic homeostasis and improves cardiovascular health","volume":"82","author":"Diab","year":"2024","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.clnesp.2026.103415_bib40","doi-asserted-by":"crossref","unstructured":"C. Delrue, R. Speeckaert, M.M. Speeckaert, The role of intermittent fasting and ketogenic diet in metabolic syndrome and type 2 diabetes, Acta Clin Belg 0 (n.d.) 1\u201315. https:\/\/doi.org\/10.1080\/17843286.2025.2540287.","DOI":"10.1080\/17843286.2025.2540287"},{"key":"10.1016\/j.clnesp.2026.103415_bib41","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.cmet.2018.04.010","article-title":"Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress Even without weight loss in men with prediabetes","volume":"27","author":"Sutton","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.clnesp.2026.103415_bib42","first-page":"185","article-title":"Effect of time-restricted feeding on insulin sensitivity and oxidative stress in a sample of prediabetes Egyptian patients","volume":"vol. 92","author":"Bassem Zahwy T. Sawers","year":"2024","journal-title":"Med J Cairo Univ"},{"key":"10.1016\/j.clnesp.2026.103415_bib44","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.clnesp.2023.11.009","article-title":"Effects of intermittent fasting regimens on glycemic, hepatic, anthropometric, and clinical markers in patients with non-alcoholic fatty liver disease: systematic review and meta-analysis of randomized controlled trials","volume":"59","author":"Saleh","year":"2024","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.clnesp.2026.103415_bib45","article-title":"Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet \u2013 a randomised controlled trial","volume":"3","author":"Holmer","year":"2021","journal-title":"JHEPReport"},{"key":"10.1016\/j.clnesp.2026.103415_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.948655","article-title":"Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: a randomized controlled trial","volume":"9","author":"Kord Varkaneh","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnesp.2026.103415_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102519","article-title":"Intermittent fasting and health outcomes: an umbrella review of systematic reviews and meta-analyses of randomised controlled trials","volume":"70","author":"Sun","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.clnesp.2026.103415_bib48","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1007\/s00125-024-06196-3","article-title":"EASL\u2013EASD\u2013EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): executive Summary","volume":"67","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnesp.2026.103415_bib49","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of non-alcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2026.103415_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-082007","article-title":"Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials","volume":"389","author":"Semnani-Azad","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.clnesp.2026.103415_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.70920","article-title":"Resmetirom: a breakthrough in the treatment of Metabolic Dysfunction\u2013Associated Steatotic Liver Disease (MASLD)","volume":"8","author":"Shakeel","year":"2025","journal-title":"Health Sci Rep"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726005127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726005127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:28:36Z","timestamp":1790018916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457726005127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":48,"alternative-id":["S2405457726005127"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.103415","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intermittent fasting strategies for metabolic dysfunction-associated steatotic liver disease: A systematic review and frequentist network meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.103415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103415"}}